¡Ya estamos en ! Descubre más
172.97 USD
-2.58
1.47%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
172.97
0.00
0%
1 día
-1.47%
5 días
0.91%
1 mes
12.54%
3 meses
27.09%
6 meses
46.27%
En lo que va del año
25.39%
1 año
22.59%
5 años
11.75%
10 años
283.1%
 

Acerca de: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Empleados: 18,200

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 42.9%
Neutral 57.1%
Negativo 0%
Neutral
Business Wire
hace 3 días
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving.
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Positivo
Zacks Investment Research
hace 4 días
Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.
Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Neutral
Seeking Alpha
hace 14 días
Dividend Champion, Contender, And Challenger Highlights: Week October 4
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Dividend Champion, Contender, And Challenger Highlights: Week October 4
Neutral
Business Wire
hace 15 días
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time.
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
Neutral
Business Wire
hace 17 días
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the.
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
Positivo
Zacks Investment Research
hace 21 días
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
Neutral
Seeking Alpha
hace 23 días
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Positivo
MarketBeat
hace 23 días
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
Agilent Technologies NYSE: A executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company's Ignite transformation program, during a J.P. Morgan conference discussion.
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
Neutral
Seeking Alpha
hace 25 días
Lithium Miners News For The Month Of September 2026
China's lithium carbonate spot prices and spodumene spot prices were significantly lower the past month. Lithium market news - China's biggest lithium mine (CATL's Jianxiawo Mine) loses its license and is back on care and maintenance. Why has Benchmark flipped 2027 lithium from Surplus to Deficit? Lithium miner news - Ganfeng Lithium swings to profit in H1 2026 as revenue nearly triples. Tianqi Lithium's profit surges 49-fold in H1 as revenue soars 153%.
Lithium Miners News For The Month Of September 2026
Neutral
Business Wire
hace 25 días
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequencing.
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
Gráficos de precios implementados con Lightweight Charts™